期刊文献+

MicroRNA-29b表达改变对卵巢癌细胞增殖及侵袭的影响 被引量:1

The role of microRNA-29bin ovarian cancer cell proliferation and invasion and its mechanism
下载PDF
导出
摘要 目的:探讨microRNA-29b(miRNA-29b)在卵巢癌细胞中的表达差异及其对卵巢癌细胞增殖和侵袭能力的影响。方法:采用real-time PCR技术检测人卵巢癌上皮细胞系SKOV-3及正常人卵巢上皮细胞系IOSE80中miRNA-29b的表达水平;采用转染技术上调SKOV-3细胞中miRNA-29b的表达水平;采用CCK-8法检测SKOV-3细胞增殖能力;采用Transwell法检测SKOV-3细胞的侵袭能力;采用Western印迹法检测SKOV-3细胞中蛋白表达水平。结果:与IOSE80细胞相比,人卵巢癌上皮细胞系SKOV-3细胞miRNA-29b的表达下降(P<0.05)。转染miRNA-29bmimic后SKOV-3细胞中miRNA-29b的表达水平增加;从第4天开始,转染miRNA-29b的SKOV3细胞增殖能力下降(P<0.05)。转染miRNA-29b减少了通过聚碳酸酯膜的SKOV3细胞数量,抑制了SKOV3细胞的侵袭能力(P<0.05);转染miRNA-29bmimic后,卵巢癌细胞SKOV3中抑制凋亡蛋白Bcl-2和侵袭相关蛋白MMP-9的表达均降低,与阴性对照组相比差异有统计学意义(P<0.05)。结论:miRNA-29b可通过抑制凋亡相关蛋白Bcl-2和侵袭相关蛋白MMP-9的表达来抑制卵巢癌细胞的增殖和侵袭。 Objective: To investigate the expression of miRNA-29 bin ovarian cancer cells and its effects on proliferation and invasion of ovarian cancer cells and the underlying mechanisms.Methods:Real-time RT-PCR was used to detect the expression level of miRNA-29 bin human ovarian cancer epithelial cell line SKOV-3 and human normal ovarian epithelial cell line IOSE80.The expression of miRNA-29 bin SKOV-3 cells was up-regulated by transfection technique.CCK-8 assay was used to detect the proliferation of SKOV-3 cells.Transwell migration assay was used to detect the invasion of SKOV-3 cells.Western blotting was used to detect the level of protein expression in SKOV-3 cells.Results:The expression of miRNA-29 bin human ovarian epithelial cell line SKOV-3 cells decreased significantly(compared with IOSE80 cells,P〈0.05).The expression level of miRNA-29 bin SKOV-3 cells was increased significantly after miRNA-29 bmimic transfection(P〈0.05).From the 4 th day,the proliferation of miRNA-29 b-transfected SKOV3 cell was significantly increased(P〈0.05).At the same time,transfection of miRNA-29 bsignificantly reduced the number of SKOV3 cells through the polycarbonate membrane and inhibited the invasiveness of SKOV3 cells(P〈0.05).After transfection of miRNA-29 bmimic,the expression of Bcl-2 and the invasion-related protein MMP-9 in the ovarian cancer cell line SKOV3 were significantly lower than those in the negative control group(P〈0.05).Conclusions:miRNA-29 bcan inhibit the proliferation and invasion of ovarian cancer cells,probably viainhibiting the expression of apoptosis related protein Bcl-2 and invasion related protein MMP-9.
作者 季晓微 王琳 徐军 刘素英 董曦 JI Xiao-wei;WANG Lin;XU Jun;LIU Su-ying;DONG Xi(Reproduction Medicine Center,Zhongshan Hospital,Fudan University,Shanghai 200032,China)
出处 《中国临床医学》 2018年第3期387-390,共4页 Chinese Journal of Clinical Medicine
关键词 miRNA-29b 卵巢癌 细胞增殖 细胞侵袭 调控机制 miRNA-29 b ovarian cancer cell proliferation cell invasion regulation mechanism
  • 相关文献

参考文献1

二级参考文献11

  • 1全国肿瘤登记中心.中国肿瘤登记工作指导手册[M].北京:中国协和医科大学出版社,2004.48-50.
  • 2Torte LA,Bray F,Siegel RL,et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015,65(2) : 87-108.
  • 3Chou JL,Su HY,Chen LY,et al. Promoter hypermethylation of FBX032,a novel TGF-p/SMAIM target gene and tumor suppressor,is associated with poor prognosis in human ovarian cancer[J]. Lab Invest, 2010,90(3) :414-425.
  • 4Curado MPEB,Shin HR,Storm H,et al. Cancer Incidence in Five Continents, Vol. Ⅸ [M].Lyon : IARC Scientific Publications, 2008.
  • 5Bray F,Parkin DM. Evaluation of data quality in the cancer registry :principles and methods. Part Ⅰ :comparability,validity and timeliness [J]. Eur J Cancer,2009,45(5): 747-755.
  • 6Parkin DM,Chen VW,Ferlay J,et al. Comparability and quality control in cancer registration. IARC technical report No. 19[M]. Lyon : IARC, 1994.
  • 7Felay J,Burkhard C,Whelan S,et al. Check and Conversion Programs for Cancer Registries. IARC Technical Report No.42[M].Lyon : IARC, 2005.
  • 8Felay J. The IARCcrgTools program[EB/OL], http ://www.iacr.com.fr/iarccrgtools.htm. IACR. Lyon. 2006.
  • 9杨念念,严亚琼,龚洁,张思维,郑荣寿,陈万青.中国2003~2007年卵巢癌发病与死亡分析[J].中国肿瘤,2012,21(6):401-405. 被引量:61
  • 10杨念念,严亚琼,郑荣寿,张思维,陈万青.中国2009年卵巢癌发病与死亡分析[J].中国肿瘤,2013,22(8):617-621. 被引量:58

共引文献164

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部